Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT05029284
- Status
- Completed
Conditions
- Stroke
- Stroke Hemorrhagic
- Stroke, Ischemic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- teleABLE — BEHAVIORALParticipants will be guided to self-monitor their daily activities, schedule personally meaningful non-sedentary activities, collaboratively problem solve to overcome barriers to the activity, and self-assess their progress. Participants may be asked to self-monitor their activity levels and complete planned activities between sessions.
Study Details
Adults with stroke-related disability spend more time sedentary than adults without stroke-related disability, which places them at risk for poor cardiovascular health outcomes. Few interventions are designed to reduce post-stroke sedentary time. The purpose of this research is to test whether the teleABLE (Activating Behavior for Lasting Engagement) Intervention is feasible and acceptable to adults within the first 12 months post-stroke. The hypothesis is that teleABLE can be feasibly delivered using videoconferencing within the first 12 months post-stroke. 10 participants will complete assessments and activity monitoring (activPAL micro3) at 0 (baseline) and 8 (post-intervention)-weeks. Participants will complete 12 sessions of the teleABLE intervention. Findings from this study will be used to guide the intervention protocol in the planned next phase of this research.
Key Dates
- Start date
- Dec 20, 2021
- Status verified
- Jun 2025
- Primary completion
- Mar 18, 2024
- Completion
- Mar 18, 2024
Study Design
- Enrollment
- 11 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: teleABLEParticipants will complete 12 teleABLE sessions via videoconferencing, guided by an intervention therapist and participant workbook.
Primary Outcome Measure
Incidence of Treatment-Emergent Adverse Events [ Time Frame: week 2 through week 7 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 | - |
Find similar trials in Minneapolis, MN
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2/PHASE3 · Recruiting · DiaMedica Therapeutics Inc · Fairhope, Alabama